{
    "organizations": [],
    "uuid": "c5383f36d2bfdacd5f3c2d93871ebbf4dc4a6d85",
    "author": "",
    "url": "https://www.reuters.com/article/brief-teva-announces-launch-of-a-generic/brief-teva-announces-launch-of-a-generic-version-of-syprine-in-the-u-s-idUSASB0C51S",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Announces Launch Of A Generic Version Of Syprine In The U.S",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Teva Announces Launch Of A Generic Version Of Syprine In The U.S Reuters Staff \nFeb 9 (Reuters) - Teva Pharmaceutical Industries Ltd : \n* TEVA ANNOUNCES LAUNCH OF A GENERIC VERSION OF SYPRINE® IN THE UNITED STATES \n* TEVA PHARMACEUTICAL INDUSTRIES LTD - ‍LAUNCH OF GENERIC VERSION OF SYPRINE (TRIENTINE HYDROCHLORIDE) CAPSULES, 250 MG, IN U.S.​ Source text for Eikon:  ",
    "published": "2018-02-09T16:11:00.000+02:00",
    "crawled": "2018-02-09T16:22:35.081+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "teva",
        "announces",
        "launch",
        "generic",
        "version",
        "syprine",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "teva",
        "announces",
        "launch",
        "generic",
        "version",
        "united",
        "state",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "generic",
        "version",
        "syprine",
        "trientine",
        "hydrochloride",
        "capsule",
        "mg",
        "source",
        "text",
        "eikon"
    ]
}